These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 1818949

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR, Lo MW, Christ DD, Chiou R, Furtek CI, Amit O, Carides A, Biollaz J, Piguet V, Nussberger J, Brunner HR.
    Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin antagonists.
    Brunner HR, Nussberger J, Waeber B.
    Adv Nephrol Necker Hosp; 1993 Jan; 22():305-27. PubMed ID: 8427061
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
    Kohzuki M, Yasujima M, Kanazawa M, Yoshida K, Fu LP, Obara K, Saito T, Abe K.
    J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats.
    Lark LA, Wappel SM, Weyhenmeyer JA.
    J Pharmacol Exp Ther; 1995 Aug; 274(2):745-51. PubMed ID: 7636738
    [Abstract] [Full Text] [Related]

  • 16. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    Hatch M, Freel RW, Shahinfar S, Vaziri ND.
    J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat.
    Macari D, Bottari S, Whitebread S, De Gasparo M, Levens N.
    Eur J Pharmacol; 1993 Nov 02; 249(1):85-93. PubMed ID: 8282023
    [Abstract] [Full Text] [Related]

  • 19. Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan.
    Hajj-Ali AF, Wong PC.
    J Pharmacol Exp Ther; 1993 Dec 02; 267(3):1423-7. PubMed ID: 7903389
    [Abstract] [Full Text] [Related]

  • 20. Clinical experience with angiotensin II receptor antagonists.
    Lee RJ, Brunner HR.
    J Hum Hypertens; 1993 Aug 02; 7 Suppl 2():S33-6. PubMed ID: 8230087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.